These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 32478671

  • 21. Efficacy and safety of long term treatment of unresponsive hypoparathyroidism using multipulse subcutaneous infusion of teriparatide.
    Díaz-Soto G, Mora-Porta M, Nicolau J, Perea V, Halperin I, Puig-Domingo M.
    Horm Metab Res; 2012 Sep; 44(9):708-10. PubMed ID: 22473758
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Continuous Teriparatide Treatment in Chronic Hypoparathyroidism: A Case Report.
    Saraiva M, Chaves AC, Assunção G, Saraiva J, Carvalho R.
    Am J Case Rep; 2021 Aug 14; 22():e931739. PubMed ID: 34389697
    [Abstract] [Full Text] [Related]

  • 24. Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism.
    Winer KK, Sinaii N, Peterson D, Sainz B, Cutler GB.
    J Clin Endocrinol Metab; 2008 Sep 14; 93(9):3389-95. PubMed ID: 18492754
    [Abstract] [Full Text] [Related]

  • 25. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V, Torregrosa V.
    Nefrologia; 2008 Sep 14; 28 Suppl 3():67-78. PubMed ID: 19018742
    [Abstract] [Full Text] [Related]

  • 26. Natpara for the treatment of hypoparathyroidism.
    Marcucci G, Della Pepa G, Brandi ML.
    Expert Opin Biol Ther; 2016 Nov 14; 16(11):1417-1424. PubMed ID: 27689826
    [Abstract] [Full Text] [Related]

  • 27. The Clinical and Skeletal Effects of Long-Term Therapy of Hypoparathyroidism With rhPTH(1-84).
    Agarwal S, McMahon DJ, Chen J, Brossfield AV, Fernando J, Bilezikian JP, Cusano NE, Rubin MR.
    J Bone Miner Res; 2023 Apr 14; 38(4):480-492. PubMed ID: 36726204
    [Abstract] [Full Text] [Related]

  • 28. Hypoparathyroidism: Replacement Therapy with Parathyroid Hormone.
    Rejnmark L, Underbjerg L, Sikjaer T.
    Endocrinol Metab (Seoul); 2015 Dec 14; 30(4):436-42. PubMed ID: 26394728
    [Abstract] [Full Text] [Related]

  • 29. Palopegteriparatide Treatment Improves Renal Function in Adults with Chronic Hypoparathyroidism: 1-Year Results from the Phase 3 PaTHway Trial.
    Rejnmark L, Gosmanova EO, Khan AA, Makita N, Imanishi Y, Takeuchi Y, Sprague S, Shoback DM, Kohlmeier L, Rubin MR, Palermo A, Schwarz P, Gagnon C, Tsourdi E, Zhao C, Makara MA, Ominsky MS, Lai B, Ukena J, Sibley CT, Shu AD.
    Adv Ther; 2024 Jun 14; 41(6):2500-2518. PubMed ID: 38691316
    [Abstract] [Full Text] [Related]

  • 30. Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.
    Kim ES, Keating GM.
    Drugs; 2015 Jul 14; 75(11):1293-303. PubMed ID: 26177893
    [Abstract] [Full Text] [Related]

  • 31. Extended Treatment With Recombinant Human Parathyroid Hormone (1-84) in Adult Patients With Chronic Hypoparathyroidism.
    Rubin MR, Cusano N, Yin S, Tokareva E, Ayodele O, Finkelman RD.
    Endocr Pract; 2024 Mar 14; 30(3):200-208. PubMed ID: 38086524
    [Abstract] [Full Text] [Related]

  • 32. Initiation of Continuous rhPTH Infusion With Insulin Pump in an Inpatient Setting.
    Lindsay Mart F, Winer KK, Johnson K, Wasserman H.
    JCEM Case Rep; 2023 Nov 14; 1(6):luad136. PubMed ID: 37954834
    [Abstract] [Full Text] [Related]

  • 33. Therapy of Hypoparathyroidism With rhPTH(1-84): A Prospective, 8-Year Investigation of Efficacy and Safety.
    Tay YD, Tabacco G, Cusano NE, Williams J, Omeragic B, Majeed R, Gomez Almonte M, Bilezikian JP, Rubin MR.
    J Clin Endocrinol Metab; 2019 Nov 01; 104(11):5601-5610. PubMed ID: 31310310
    [Abstract] [Full Text] [Related]

  • 34. Recombinant human parathyroid hormone (1-84) is effective in CASR-associated hypoparathyroidism.
    Hawkes CP, Shulman DI, Levine MA.
    Eur J Endocrinol; 2020 Dec 01; 183(6):K13-K21. PubMed ID: 33112267
    [Abstract] [Full Text] [Related]

  • 35. Therapy with PTH 1-34 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27 years at a single tertiary care center.
    Winer KK, Ye S, Ferré EMN, Schmitt MM, Zhang B, Cutler GB, Lionakis MS.
    Bone; 2021 Aug 01; 149():115977. PubMed ID: 33932619
    [Abstract] [Full Text] [Related]

  • 36. The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics.
    Gittoes N, Rejnmark L, Ing SW, Brandi ML, Björnsdottir S, Hahner S, Hofbauer LC, Houillier P, Khan AA, Levine MA, Mannstadt M, Shoback DM, Vokes TJ, Zhang P, Marelli C, Germak J, Clarke BL.
    BMC Endocr Disord; 2021 Nov 20; 21(1):232. PubMed ID: 34801015
    [Abstract] [Full Text] [Related]

  • 37. Five-year Estimated Glomerular Filtration Rate in Patients With Hypoparathyroidism Treated With and Without rhPTH(1-84).
    Chen KS, Gosmanova EO, Curhan GC, Ketteler M, Rubin M, Swallow E, Zhao J, Wang J, Sherry N, Krasner A, Bilezikian JP.
    J Clin Endocrinol Metab; 2020 Oct 01; 105(10):e3557-65. PubMed ID: 32738041
    [Abstract] [Full Text] [Related]

  • 38. Long-Term Parathyroid Hormone 1-34 Replacement Therapy in Children with Hypoparathyroidism.
    Winer KK, Kelly A, Johns A, Zhang B, Dowdy K, Kim L, Reynolds JC, Albert PS, Cutler GB.
    J Pediatr; 2018 Dec 01; 203():391-399.e1. PubMed ID: 30470382
    [Abstract] [Full Text] [Related]

  • 39. Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment.
    Marcucci G, Beccuti G, Carosi G, Cetani F, Cianferotti L, Colao AM, Di Somma C, Duradoni M, Elefante A, Ghizzoni L, Giusti M, Lania AG, Lavezzi E, Madeo B, Mantovani G, Marcocci C, Masi L, Parri S, Pigliaru F, Santonati A, Spada A, Vera L, Brandi ML.
    J Endocrinol Invest; 2022 Sep 01; 45(9):1653-1662. PubMed ID: 35460461
    [Abstract] [Full Text] [Related]

  • 40. Hypoparathyroidism.
    Al-Azem H, Khan AA.
    Best Pract Res Clin Endocrinol Metab; 2012 Aug 01; 26(4):517-22. PubMed ID: 22863393
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.